Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 2Postoperative Nausea and Vomiting 1Pain, Postoperative 1Pain 1Intracranial Aneurysm 1Hyperalgesia 1Fibrosis 1Diabetes Mellitus 1Breast Neoplasms 1

Interventions

Temozolomide 162Radiosurgery 114Radiotherapy 99Bevacizumab 95Magnetic Resonance Spectroscopy 64Carboplatin 48Etoposide 34Surgical Procedures, Operative 33Irinotecan 33pembrolizumab 32Nivolumab 32Cyclophosphamide 32Erlotinib Hydrochloride 31Radiation 29Carmustine 28Cisplatin 25Lomustine 24Trastuzumab 23Ipilimumab 23Filgrastim 23Vincristine 20Mental Status and Dementia Tests 20Aminolevulinic Acid 19Topotecan 18Pemetrexed 18Capecitabine 18Specimen Handling 17Sorafenib 15Radiotherapy, Intensity-Modulated 15Imatinib Mesylate 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Brain Neoplasms × esmolol × Clear all
NCT02563288 2017-07-27

Esmolol Versus Dexmedetomidine During Intracranial Procedures

George Papanicolaou Hospital

Phase 3 Unknown
60 enrolled
CNS

Brain Neoplasms, Intracranial Aneurysm

NCT01951950 2014-08-29

Nicardipine vs Esmolol Craniotomy Emergence

Northwestern University

Phase 1 Completed
40 enrolled 6 charts
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡